NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd. (NRSN) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: June 16, 2026 , by Eisenberg Or .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Eisenberg Or | Chief Financial Officer | Buy | 250,000 | $0.80 | $200.0K | 1,504,050 | |
| Ben-Noon Alon | Chief Executive Officer | Buy | 250,000 | $0.80 | $200.0K | 4,534,233 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.